Pfizer COVID vaccine shown highly protective in teens against Delta
The estimated effectiveness of the Pfizer/BioNTech COVID-19 vaccine against infection in US adolescents was 91%, with 93% protection against symptomatic illness and 85% against asymptomatic disease amid the Delta SARS-CoV-2 surge in Connecticut, finds a study published yesterday in JAMA Network Open.